Literature DB >> 10229859

Selection of HIV-specific immunogenic epitopes by screening random peptide libraries with HIV-1-positive sera.

G Scala1, X Chen, W Liu, J N Telles, O J Cohen, M Vaccarezza, T Igarashi, A S Fauci.   

Abstract

Efforts to develop a protective HIV-1 vaccine have been hindered by difficulties in identifying epitopes capable of inducing broad neutralizing Ab responses. In fact, the high mutation rate occurring in HIV-1 envelope proteins and the complex structure of gp120 as an oligomer associated with gp41 result in a high degree of antigenic polymorphism. To overcome these obstacles, we screened random peptide libraries using sera from HIV-infected subjects to identify antigenic and immunogenic mimics of HIV-1 epitopes. After extensive counterscreening with HIV-negative sera, we isolated peptides specifically recognized by Abs from HIV-1-infected individuals. These peptides behaved as antigenic mimics of linear or conformational HIV-1 epitopes generated in vivo in infected subjects. Consistent with these findings, sera of simian HIV-infected monkeys also recognized the HIV-specific epitopes. The selected peptides were immunogenic in mice, where they elicited HIV-specific Abs that effectively neutralized HIV-1 isolates. These results demonstrate that pools of HIV-1 mimotopes can be selected from combinatorial peptide libraries by taking advantage of the HIV-specific Ab repertoire induced by the natural infection.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10229859

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  37 in total

1.  Exploring peptide mimics for the production of antibodies against discontinuous protein epitopes.

Authors:  Melita B Irving; Lisa Craig; Alfredo Menendez; Beechanahalli P Gangadhar; Marinieve Montero; Nienke E van Houten; Jamie K Scott
Journal:  Mol Immunol       Date:  2009-12-23       Impact factor: 4.407

2.  Specific and randomly derived immunoactive peptide mimotopes of mycobacterial antigens.

Authors:  Archna Sharma; Abhik Saha; Surajit Bhattacharjee; Subrata Majumdar; Sujoy K Das Gupta
Journal:  Clin Vaccine Immunol       Date:  2006-08-17

3.  Synthesis of a trimeric gp120 epitope mimic conjugated to a T-helper peptide to improve antigenicity.

Authors:  Joan G Schellinger; Lieza M Danan-Leon; Jessica A Hoch; Aemro Kassa; Indresh Srivastava; David Davis; Jacquelyn Gervay-Hague
Journal:  J Am Chem Soc       Date:  2011-02-22       Impact factor: 15.419

4.  Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies.

Authors:  Ming Li; Feng Gao; John R Mascola; Leonidas Stamatatos; Victoria R Polonis; Marguerite Koutsoukos; Gerald Voss; Paul Goepfert; Peter Gilbert; Kelli M Greene; Miroslawa Bilska; Denise L Kothe; Jesus F Salazar-Gonzalez; Xiping Wei; Julie M Decker; Beatrice H Hahn; David C Montefiori
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

5.  Novel biopanning strategy to identify epitopes associated with vaccine protection.

Authors:  Barbara C Bachler; Michael Humbert; Brisa Palikuqi; Nagadenahalli B Siddappa; Samir K Lakhashe; Robert A Rasmussen; Ruth M Ruprecht
Journal:  J Virol       Date:  2013-02-06       Impact factor: 5.103

6.  A non-chromatographic method for the purification of a bivalently active monoclonal IgG antibody from biological fluids.

Authors:  Başar Bilgiçer; Samuel W Thomas; Bryan F Shaw; George K Kaufman; Vijay M Krishnamurthy; Lara A Estroff; Jerry Yang; George M Whitesides
Journal:  J Am Chem Soc       Date:  2009-07-08       Impact factor: 15.419

Review 7.  Bacteriophages and phage-inspired nanocarriers for targeted delivery of therapeutic cargos.

Authors:  Mahdi Karimi; Hamed Mirshekari; Seyed Masoud Moosavi Basri; Sajad Bahrami; Mohsen Moghoofei; Michael R Hamblin
Journal:  Adv Drug Deliv Rev       Date:  2016-03-17       Impact factor: 15.470

8.  Standardized assessment of NAb responses elicited in rhesus monkeys immunized with single- or multi-clade HIV-1 envelope immunogens.

Authors:  Michael S Seaman; Daniel F Leblanc; Lauren E Grandpre; Melissa T Bartman; David C Montefiori; Norman L Letvin; John R Mascola
Journal:  Virology       Date:  2007-06-27       Impact factor: 3.616

9.  Peptide mimotopes selected from a random peptide library for diagnosis of Epstein-Barr virus infection.

Authors:  Joanne L Casey; Andrew M Coley; Graham Street; Kathy Parisi; Peter L Devine; Michael Foley
Journal:  J Clin Microbiol       Date:  2006-03       Impact factor: 5.948

10.  Evolution of antibody landscape and viral envelope escape in an HIV-1 CRF02_AG infected patient with 4E10-like antibodies.

Authors:  Tessa Dieltjens; Leo Heyndrickx; Betty Willems; Elin Gray; Lies Van Nieuwenhove; Katrijn Grupping; Guido Vanham; Wouter Janssens
Journal:  Retrovirology       Date:  2009-12-14       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.